Profusa, a commercial stage digital health company, announced its financial results for the third quarter of 2025.
The company successfully recapitalized, reducing net debt to $14 million as of October 31.
Key operational milestones were achieved, including manufacturing build-out and entering into various collaborations.
Profusa aims to achieve significant revenue targets by 2030 through strategic planning and market opportunities.
Recapitalization Success
Reduced net debt from $34 million to $14 million by raising capital and executing debt reduction strategies.
Operational Milestones
Completed the merger with NorthView Acquisition Corporation, expanded sales footprint, and entered clinical collaborations.
Financial Achievements
Raised $12 million from convertible PIPE note, $7 million from ELOC, and reduced net debt by $34 million to $14 million.
- The successful recapitalization and reduction of net debt enhance Profusa's financial stability and growth potential.
- Expansion of sales footprint and collaborations strengthen the company's market presence and revenue streams.
- By aiming for significant revenue targets by 2030, Profusa sets ambitious goals and strategic direction for future growth.
Profusa's third quarter performance reflects strategic financial and operational achievements, positioning the company for future growth and success in the digital health industry.